During the past decade, Allergy Associates Research Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 11 clinical trials were completed, i.e. on average, 137.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy Associates Research Center" #1 sponsor was "Sunovion" with 11 trials, followed by "Allergy Therapeutics" with 3 trials sponsored, "Sunovion Respiratory Development Inc." with 3 trials sponsored, "Teva Branded Pharmaceutical Products R&D, Inc." with 3 trials sponsored and "Amphastar Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allergy Associates Research Center" #1 collaborator was "PPD" with 1 trials as a collaborator, "Pacira Pharmaceuticals, Inc" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Allergy Associates Research Center" are "Asthma" (18 trials), "COPD" (4 trials), "Chronic Obstructive Pulmonary Disease" (4 trials), "Perennial Allergic Rhinitis" (4 trials) and "Type I Hypersensitivity" (3 trials). Many other conditions were trialed in "Allergy Associates Research Center" in a lesser frequency.

Most popular intervention types in "Allergy Associates Research Center" are "Drug" (33 trials), "Biological" (5 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Grass MATA MPL" (3 trials), "Ciclesonide nasal aerosol 37 mcg" (2 trials), "SUN-101 50 mcg BID eFlow (CS) nebulizer" (2 trials) and "Salmeterol" (2 trials). Other intervention names were less common.

The vast majority of trials in "Allergy Associates Research Center" are 39 trials for "All" genders.

Currently, there are NaN active trials in "Allergy Associates Research Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Allergy Associates Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Allergy Associates Research Center, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".